This makes targeted taxation a promising lever to help slow antimicrobial resistance—though always with care to protect patients who truly need broad-spectrum coverage.
Open access 👉 doi.org/10.1016/j.ij...
Using UK sales data, we show that taxes on all antibiotics cut broad-spectrum use only modestly—& at high cost. But targeted taxes on AMR-promoting broad-spectrum drugs cut use much more, shift demand toward narrow-spectrum, & cause minimal welfare loss.
#HealthEconomics
Thrilled our paper has won Best Empirical Paper in IJIO at #EARIE2025! 🎉 Huge thanks to my brilliant co-authors, Weijie Yan (Owen) & Franco Mariuzzo, and to the editors & referees for their feedback.
#IJIO #EARIE2025
